Protagonist Therapeutics Inc (PTGX)
Debt-to-assets ratio
| Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total assets | US$ in thousands | 629,276 | 357,951 | 330,016 | 320,466 | 239,858 | 247,928 | 282,174 | 310,512 | 348,296 | 347,695 | 373,175 | 404,232 | 298,072 | 324,468 | 217,320 | 224,980 | 134,901 | 154,917 | 154,627 | 148,105 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
March 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $629,276K
= 0.00
The debt-to-assets ratio of Protagonist Therapeutics Inc has consistently been reported as 0.00 across multiple reporting periods. This suggests that the company has not utilized debt financing to fund its operations or investments, and its assets are primarily financed through equity. A debt-to-assets ratio of 0.00 indicates that the company's assets are fully funded by equity, which may be perceived positively by investors and creditors as it implies a lower financial risk due to the absence of debt obligations. However, it is essential to consider other financial ratios and metrics in conjunction with the debt-to-assets ratio to get a holistic view of the company's overall financial health and capital structure.
Peer comparison
Mar 31, 2024